Guanfacine Tablet, Extended Release
Product Images NDC 70518-4675

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 70518-4675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text is about Guanfacine Extended-Release 2mg Tablets manufactured by Unichem in Ghaziabad, India. The usual dosage information is available in the insert. The medication should be kept out of the reach of children and stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). The quantity is 30 tablets. The tablets are round and white with an imprint "42" and "U." The medication is repackaged by RemedyRepack Inc. in Indiana, PA. Contact number: 724-465-8762.*

FDA Label Image

Figure 01 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 01)

FDA Label Image

Image (Bc9cc5d2 E098 41da Ae90 0944715d6b92 02)

FDA Label Image

Figure 2 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 03)

FDA Label Image

Figure 3 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 04)

This text seems to refer to a comparison or analysis related to two drugs - "Oral Methylphenidate" and "Lisdexamfetamine Dimesylate". The text also mentions something about a change relative to reference and percentage change. It may be part of a study or report comparing the efficacy or impact of these drugs.*

FDA Label Image

Figure-04 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.